Sarab Lizard‐Nacol
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
- Oncology 15
- Cancer-related Molecular Pathways 10
- HER2/EGFR in Cancer Research 2
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Frédérique Végran (14 shared papers)Romain Boidot (14 shared papers)Claude Turc‐Carel (5 shared papers)Eve Justrabo (2 shared papers)Thierry O. Philip (2 shared papers)Marie Favrot (2 shared papers)Jean‐Marc Riedinger (8 shared papers)Éric Tabone (1 shared paper)
In The Last Decade
Sarab Lizard‐Nacol
32 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 67
- Cancer Research 315
- Oncology 373
- Pathology and Forensic Medicine 171
- Pulmonary and Respiratory Medicine 293
- Molecular Biology 600
Countries citing papers authored by Sarab Lizard‐Nacol
This map shows the geographic impact of Sarab Lizard‐Nacol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarab Lizard‐Nacol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarab Lizard‐Nacol more than expected).
Fields of papers citing papers by Sarab Lizard‐Nacol
This network shows the impact of papers produced by Sarab Lizard‐Nacol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarab Lizard‐Nacol. The network helps show where Sarab Lizard‐Nacol may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarab Lizard‐Nacol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 208 | |
| 2 | 2011 | 191 | |
| 3 | 2013 | 61 | |
| 4 | 2006 | 60 | |
| 5 | 2006 | 58 | |
| 6 | 1999 | 50 | |
| 7 | 2002 | 43 | |
| 8 | 2005 | 41 | |
| 9 | 2010 | 41 | |
| 10 | 2008 | 40 | |
| 11 | Immunologic characterization of Ewing's sarcoma using mesenchymal and neural markers. | 1989 | 39 |
| 12 | 2013 | 38 | |
| 13 | Benign breast disease: absence of genetic alterations at several loci implicated in breast cancer malignancy. | 1995 | 33 |
| 14 | 1987 | 29 | |
| 15 | 2009 | 28 | |
| 16 | 1988 | 26 | |
| 17 | 2011 | 26 | |
| 18 | 2013 | 26 | |
| 19 | MDR1 and thymidylate synthase (TS) gene expressions in advanced breast cancer: relationships to drug exposure, p53 mutations, and clinical outcome of the patients. | 2000 | 21 |
| 20 | 2000 | 20 |
About Sarab Lizard‐Nacol
Sarab Lizard‐Nacol is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Cell death mechanisms and regulation (7 papers), Genetic factors in colorectal cancer (5 papers), Sarcoma Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers), Neuroblastoma Research and Treatments (2 papers), Breast Lesions and Carcinomas (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Cancer Research (315 citations), Oncology (373 citations), Pathology and Forensic Medicine (171 citations), Pulmonary and Respiratory Medicine (293 citations) and Molecular Biology (600 citations). Sarab Lizard‐Nacol has collaborated with scholars based in France, Belgium and Poland. Frequent co-authors include Frédérique Végran, Romain Boidot, Claude Turc‐Carel, Eve Justrabo, Thierry O. Philip, Marie Favrot, Jean‐Marc Riedinger, Éric Tabone, Claire Oudin and Olivier Féron. Their work appears in journals such as International Journal of Oncology, Cancer Research, Oncogene, Molecular Biology Reports and International Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.